NTRK2 Fusion Positive

DrugDrug NameDrug Description
DB14723LarotrectinibA kinase inhibitor used to treat solid tumors with neurotrophic receptor tyrosine kinase gene fusion, are metastatic, high risk for surgery, or have no alternative treatments.
DrugDrug NamePhaseStatusCount
DB11791Capmatinib2Terminated1
DB09063Ceritinib2Terminated1
DB11986Entrectinib2Terminated1
DB08896Regorafenib2Terminated1